Developing a Human Factors Validation Plan with Consideration for the Digital Health Marketplace This workshop will provide an overview of human factors validation strategies that companies should consider as the pre-filled syringe market increasingly takes […]
Researchers at Mount Sinai in the US have developed a new immunotherapy that can be injected directly into a tumour cell and teach a patient’s own immune system to kill cancer throughout the body. Called in […]
Alnylam Pharmaceuticals and Regeneron Pharmaceuticals announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of diseases by addressing disease targets expressed in the eye and central nervous […]
Sun Pharmaceutical Industries Ltd. announced that INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the first chemotherapy product that comes in a premixed, ready-to-infuse formulation, was […]
Examining the evolving technological and commercial landscape to enhance your precision medicine development Come join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and […]